About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Immunotherapy Drug Adds Value to Chemotherapy for HER-2 Positive Gastric Cancer

by Dr. Trupti Shirole on November 16, 2015 at 10:23 AM
Font : A-A+

 Immunotherapy Drug Adds Value to Chemotherapy for HER-2 Positive Gastric Cancer

Gastric cancer, also known as stomach cancer, is the third most common cause of cancer-related death in the world. The prognosis for patients with stomach cancer is poor. In western countries even patients with localized gastric or gastro-esophageal junction adenocarcinoma are faced with five-year survival rates of approximately 35% after standard perioperative chemotherapy and curative surgery.

10-20% of gastric cancers overexpress the Human Epidermal growth factor Receptor 2 (HER-2). There might be a more effective treatment plan for such patients. Addition of the monoclonal antibody trastuzumab to standard chemotherapy improves survival significantly in patients with advanced HER-2 positive gastric cancer.

Advertisement


Dr. Anna Dorothea Wagner of Center Hospitalier Universitaire Vaudois - Lausanne in Switzerland and Coordinator of this study said, "Considering that HER-2 targeted treatment with trastuzumab has been shown to improve survival in early, HER-2 positive breast cancer when given in addition to chemotherapy either before (neoadjuvant) or after surgery (adjuvant), as well as in patients with advanced, HER-2 positive gastric cancer, I found it difficult not to administer this drug in patients with early, HER-2 positive gastric cancer when we know that efficient systemic therapy increases the chance for long-term survival."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
Test Your Knowledge on Sugar Intake and Oral Health
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Gastric Cancer Cancer and Homeopathy Immunisation Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Signature Drug Toxicity 

Most Popular on Medindia

Pregnancy Confirmation Calculator Post-Nasal Drip Hearing Loss Calculator Calculate Ideal Weight for Infants Turmeric Powder - Health Benefits, Uses & Side Effects Blood - Sugar Chart Loram (2 mg) (Lorazepam) Color Blindness Calculator How to Reduce School Bag Weight - Simple Tips Daily Calorie Requirements
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Immunotherapy Drug Adds Value to Chemotherapy for HER-2 Positive Gastric Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests